AcelRx Pharmaceuticals Inc expected to post a loss of $1.20 a share - Earnings Preview

Talphera

11/11/2022 23:55

* AcelRx Pharmaceuticals Inc  ACRX.OQ   ACRX.O  is expected
to show a fall in quarterly revenue when it reports  results on
November 14. 
    * The Hayward California-based  company is expected to
report  a
66.4% decrease in revenue to $625 thousand from $1.86 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AcelRx
Pharmaceuticals
Inc is for a loss of $1.20 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AcelRx
Pharmaceuticals Inc is $80​, above​ its last closing price
of $2.06. ​​​

This summary was machine generated November 11 at 23:55 GMT. 
All figures in US dollars  unless otherwise stated